logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On June 20th, MNSO (09896) spent approximately $224,600 to repurchase 52,000 shares.

date
22/06/2025
avatar
GMT Eight
Miniso (09896) announced that on June 20, 2025, it will spend approximately $224,600 to repurchase 52,000...
MNSO (09896) announced that on June 20, 2025, it will spend approximately $224,600 to repurchase 52,000 shares.
Related Articles
China Stock
Industrial: Pay attention to the direction of improvement in mid-year performance after shrinking the circles at both ends of the dumbbell.
Hong Kong stock concept tracking | The suspense of the Strait of Hormuz rises again, oil prices may surge to the range of 120-130 US dollars (with concept stocks)
HK Stock
IMMUNEONCO-B(01541): IMC-003/IMM72 approved by the National Medical Products Administration for clinical trials.
Industrial: Pay attention to the direction of improvement in mid-year performance after shrinking the circles at both ends of the dumbbell.
China Stock
Hong Kong stock concept tracking | The suspense of the Strait of Hormuz rises again, oil prices may surge to the range of 120-130 US dollars (with concept stocks)
IMMUNEONCO-B(01541): IMC-003/IMM72 approved by the National Medical Products Administration for clinical trials.
HK Stock
RECOMMEND
XPeng Motors Faces Whistleblower Allegations Over Steering Design Flaw and Concealment
XPeng Motors Faces Whistleblower Allegations Over Steering Design Flaw and Concealment
icon
20/06/2025
After Foundation Models, Intelligent Agents Take Center Stage as Tech Firms Accelerate Deployment | Live from MWC Shanghai
After Foundation Models, Intelligent Agents Take Center Stage as Tech Firms Accelerate Deployment | Live from MWC Shanghai
icon
20/06/2025
Ministry of Commerce: Online Retail Sales Increased by 8.5% from January to May
Ministry of Commerce: Online Retail Sales Increased by 8.5% from January to May
icon
20/06/2025
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.